Bulletin
Investor Alert

New York Markets Open in:

AstraZeneca PLC

LON: UK:AZN

GO
/marketstate/country/uk

Market open

AZN
/zigman2/quotes/203048482/delayed

9,676.00

p

Change

-268.00 -2.70%

Volume

Volume 340,874

Oct 3, 2022, 12:19 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203048482/delayed

Previous close

9,944.00 p

9,676.00 p

Change

-268.00 -2.70%

Day low

Day high

9,667p

9,819p

Open
Open: 9,806.00

52 week low

52 week high

8,090p

11,540p

Open

Market cap

£154.08B

Average volume

2.31M

P/E ratio

N/A

Rev. per Employee

£399,908

EPS

-0.60

Dividend

76.40

Div yield

2.29%

Ex dividend date

8/11/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/uk/azn

MarketWatch News on AZN

  1. AstraZeneca weighing bid for Mereo BioPharma: report

    3:44 a.m. June 17, 2022

    - Steve Goldstein

  2. Japan approves Novavax as fourth COVID-19 vaccine amid new surge

    11:26 p.m. April 19, 2022

    - Associated Press

  3. India extends COVID-19 boosters to all adults; some must pay

    11:27 p.m. April 10, 2022

    - Associated Press

  4. Loading more headlines...
/news/nonmarketwatch/company/uk/azn

Other News on AZN

  1. Roche’s Immunotherapy Drug Extended Patients’ Lives

    10:20 p.m. Dec. 7, 2017

    - The Wall Street Journal Interactive Edition

  2. In U.K., Barriers Rising Against Foreign Deals

    10:28 a.m. May 11, 2015

    - The Wall Street Journal Interactive Edition

  3. Celgene Profit Surges, Driven by Revlimid Sales

    8:18 a.m. April 30, 2015

    - The Wall Street Journal Interactive Edition

  4. AstraZeneca Reports Fall in First-Quarter Profit

    8:26 a.m. April 24, 2015

    - The Wall Street Journal Interactive Edition

  5. Billion-Dollar Health Startups

    5:21 p.m. Feb. 27, 2015

    - The Wall Street Journal Interactive Edition

  6. Valeant to Buy Salix for About $10 Billion

    9:44 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  7. New Cancer Technology Cheers Investors

    4:35 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  8. Valeant Nears Deal to Buy Salix

    2:58 p.m. Feb. 22, 2015

    - The Wall Street Journal Interactive Edition

  9. Actavis Changing Name to Allergan

    12:24 p.m. Feb. 18, 2015

    - The Wall Street Journal Interactive Edition

  10. Pharma Must Launch Itself Back

    8:17 p.m. Feb. 16, 2015

    - The Wall Street Journal Interactive Edition

  11. Corporate Watch: News Digest

    12:42 a.m. Feb. 6, 2015

    - The Wall Street Journal Interactive Edition

  12. AstraZeneca Deals Up a Tricky 2015

    12:55 p.m. Feb. 5, 2015

    - The Wall Street Journal Interactive Edition

  13. Pfizer to Buy Hospira for $16 Billion

    11:22 a.m. Feb. 6, 2015

    - The Wall Street Journal Interactive Edition

  14. Astra to Buy Actavis Portfolio

    7:54 a.m. Feb. 5, 2015

    - The Wall Street Journal Interactive Edition

  15. New Outsourcing Frontier in India: Monitoring Drug Safety

    11:20 p.m. Feb. 2, 2015

    - The Wall Street Journal Interactive Edition

  16. AstraZeneca to Harness Benefits of Genome-Editing Technology

    7:06 a.m. Jan. 29, 2015

    - The Wall Street Journal Interactive Edition

  17. Pfizer Sales Hit by Stronger Dollar

    10:53 p.m. Jan. 27, 2015

    - The Wall Street Journal Interactive Edition

  18. Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

    6:07 p.m. Jan. 26, 2015

    - The Wall Street Journal Interactive Edition

  19. Peter Wallenberg Dies at 88

    4:26 p.m. Jan. 19, 2015

    - The Wall Street Journal Interactive Edition

  20. Pharma Grows Itself a New Challenge -- Overheard

    7:51 p.m. Jan. 13, 2015

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/uk/azn

Press Releases on AZN

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.